PNEUMOGUARD 13

PNEUMOGUARD 13 - Protect Your Child from Pneumococcal Disease

Ensure your child's health and safety with PNEUMOGUARD 13, a pneumococcal conjugate vaccine developed in China, procured by G.C. Chemie Pharmie Ltd, and remarketed by Dr. Reddy's Laboratories. Trusted by healthcare professionals, PNEUMOGUARD 13 offers robust protection against pneumococcal disease, which can lead to severe infections such as pneumonia, meningitis, and bloodstream infections.

Key Benefits:

Comprehensive Protection: Safeguards your child against 13 strains of pneumococcal bacteria.

Clinically Proven: Supported by rigorous clinical trials and approved by global health authorities.

Safe and Effective: Known for its high efficacy and low incidence of side effects.

Health Conditions: Particularly recommended for children with chronic health issues or compromised immune systems.

School Requirements: Complies with vaccination mandates for schools and daycare centers.

Active Compound:

The active ingredient in PNEUMOGUARD 13 is a pneumococcal polysaccharide conjugate vaccine. It contains purified capsular polysaccharides from 13 strains of Streptococcus pneumoniae (pneumococcus). These polysaccharides are conjugated to a tetanus toxoid (TT) protein, a carrier protein. The use of TT as a carrier protein enhances the immune response, making the vaccine highly effective, especially in young children.

Polysaccharides:

Derived from the capsules of 13 different serotypes of Streptococcus pneumoniae.

These serotypes are: 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F.

Carrier Protein (Tetanus Toxoid - TT):

A highly purified and non-toxic form of the tetanus protein, used to enhance the immune system's response to the polysaccharides.

This conjugation ensures a strong and long-lasting immune response, particularly in infants and young children.

Schedule and Dosage:

Dosage: Administered in a series of 4 doses.

Timing: Initial dose at 2 months, subsequent doses at 4 months, 6 months, 

What to Expect:

Common Side Effects: Mild reactions including redness or swelling at the injection site, low-grade fever, and fussiness.

Post-Vaccination Care: Use a cool compress on the injection site to alleviate any discomfort and monitor for any unusual reactions.

Why Choose PNEUMOGUARD 13?

Expert Recommendation: Endorsed by pediatricians for its reliability and effectiveness.

Innovative Technology: Uses tetanus toxoid (TT) as a carrier protein, ensuring a robust immune response.

Global Collaboration: Developed in collaboration with a trusted source in China, adhering to international quality standards.

Peace of Mind: Provides parents with confidence in their child’s health and well-being.

Ensure your child is protected with PNEUMOGUARD 13, a vaccine that combines safety, efficacy, and comprehensive coverage against pneumococcal disease. Developed with advanced technology and trusted worldwide, it is a reliable choice for your child's immunization needs.